tiprankstipranks
Trending News
More News >
Praxis Precision Medicines (PRAX)
NASDAQ:PRAX
US Market

Praxis Precision Medicines (PRAX) Financial Statements

Compare
938 Followers

Praxis Precision Medicines Financial Overview

Praxis Precision Medicines's market cap is currently $9.21B. The company's EPS TTM is $-3.5; its P/E ratio is -24.55; Praxis Precision Medicines is scheduled to report earnings on February 19, 2026, and the estimated EPS forecast is $-3.60. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 8.55M$ 2.45M$ 0.00$ 0.00
Gross Profit$ -140.00K$ -143.86M$ -84.32M$ -154.44M$ 0.00
Operating Income$ -326.20M$ -200.16M$ -126.37M$ -214.99M$ -167.33M
EBITDA$ -303.13M$ -199.81M$ -125.94M$ -213.57M$ -167.15M
Net Income$ -303.27M$ -182.82M$ -123.28M$ -214.03M$ -167.06M
Balance Sheet
Cash & Short-Term Investments$ 599.33M$ 392.57M$ 81.30M$ 100.49M$ 275.91M
Total Assets$ 937.91M$ 483.11M$ 87.95M$ 115.13M$ 292.75M
Total Debt$ 110.00K$ 1.37M$ 2.50M$ 3.50M$ 4.31M
Net Debt$ -357.22M$ -214.00M$ -78.81M$ -58.12M$ -134.39M
Total Liabilities$ 59.77M$ 37.66M$ 18.28M$ 39.02M$ 41.94M
Stockholders' Equity$ 878.14M$ 445.45M$ 69.67M$ 76.11M$ 250.81M
Cash Flow
Free Cash Flow$ -249.12M$ -131.76M$ -111.19M$ -185.49M$ -125.60M
Operating Cash Flow$ -249.07M$ -131.76M$ -111.14M$ -185.04M$ -124.55M
Investing Cash Flow$ -311.15M$ -248.49M$ 38.95M$ 96.89M$ -140.52M
Financing Cash Flow$ 702.17M$ 514.32M$ 91.87M$ 10.46M$ 107.59M
Currency in USD

Praxis Precision Medicines Earnings and Revenue History

Praxis Precision Medicines Debt to Assets

Praxis Precision Medicines Cash Flow

Praxis Precision Medicines Forecast EPS vs Actual EPS